BIOMERIEUX
-
EUR
(-)
- 15 min delayed data - Euronext Paris
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | BIM |
| ISIN: | FR0013280286 |
BIOMERIEUX news, videos and press releases - Page 2
For more news please use our advanced search feature.
BIOMERIEUX - More news...
BIOMERIEUX - More news...
- 04/09/2020 - 18:02 bioMérieux’s Annual General Meeting Postponed
- 03/27/2020 - 06:53 bioMérieux: Regulated Information – Disclosure of Trading in Own Shares
- 03/24/2020 - 06:00 bioMérieux Receives Emergency Use Authorization for BIOFIRE® COVID-19 Test
- 03/19/2020 - 19:07 bioMérieux: Regulated Information – Disclosure of Trading in Own Shares
- 03/11/2020 - 06:00 First of 3 Diagnostic Tests for SARS-CoV-2 Coronavirus Available from bioMérieux
- 02/26/2020 - 06:00 bioMérieux – 2019 Financial Results
- 01/14/2020 - 06:00 bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance
- 12/18/2019 - 06:00 bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries
- 12/12/2019 - 15:16 bioMérieux: Regulated Information – Disclosure of Trading in Own Shares
- 12/09/2019 - 10:21 bioMérieux: Regulated Information – Disclosure of Trading in Own Shares
- 10/22/2019 - 05:00 bioMérieux – Third-Quarter 2019 Business Review
- 10/14/2019 - 08:00 Clayton, Dubilier & Rice Expands European Healthcare Team with Appointment of Jean-Luc Belingard, former CEO of bioMérieux, Ipsen, and Roche Diagnostics, as an Operating Advisor to its Funds
- 03/13/2017 - 12:30 Astute Medical Expands Relationship With bioMérieux, Inc. And Ortho Clinical Diagnostics To Enhance NephroCheck Test Market Access
-
02/08/2017 - 10:51
bioMerieux
- 12/13/2016 - 10:13 ITL BioMedical Announces Distribution Agreement with bioMérieux Canada
- 12/13/2016 - 10:13 ITL BioMedical Announces Distribution Agreement with bioMérieux Canada
- 08/02/2016 - 13:00 bioMérieux Submits 510(k) Application to the FDA for BacT/ALERT® VIRTUO™ Next Generation Automated Blood Culture system
